CD274 and neoplasm: ORR per BICR was higher in the NIVO + Chemo arm than in the Chemo arm, with the complete response rate increasing > 5 times for patients with tumor-cell PD-L1 ≥ 1% and > 4 times for all randomized patients (Table 2).